This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Oncology  • Oncology, Other  • Articles for Residents  • Ocular/ Adnexal Tumors  • Enucleation  • Dermatology  • Melanoma  • Alert me on articles by topic

Rajendra S. Apte, MD, PhD; Jerry Y. Niederkorn, PhD; Elizabeth Mayhew, BS; Hassan Alizadeh, PhD

Arch Ophthalmol. 2001;119:1805-1809.

Objectives  To evaluate the ability of human uveal melanomas to produce angiostatin in vitro and the effect of angiostatin on the development of liver metastases in vivo.

Methods  Human uveal melanoma cell lines (OCM1, OCM3, MEL202, MEL285, 92-1, OM431, and OMM1) were assayed for their ability to produce angiostatin in vitro by an angiostatin bioassay and by Western blot analysis. The OCM3 and OMM1 tumor cells were inoculated either in the posterior or the anterior segment of nude mice. One group of mice in each experiment underwent enucleation and hepatic metastases were assayed by histopathologic and liver function analysis.

Results  OCM1, OCM3, and 92-1 cell lines significantly inhibited bovine endothelial cell proliferation in vitro and generated 38-Kd angiostatin molecules. Enucleation of eyes containing OCM3 in the posterior segment resulted in a higher number of metastatic foci (26.5) in that group compared with the nonenucleated group of mice (11.17). After enucleation, elevated levels of serum aspartate transaminase and alanine aminotransferase were observed in mice bearing OCM3 in either anterior or posterior segments. The enucleation of eyes containing OMM1 (nonangiostatin–producing cells) had no significant effect on liver metastasis.

Conclusion  By removing a source of angiostatin, enucleation of melanoma-containing eyes may unwittingly exacerbate the metastatic potential of uveal melanomas.

Clinical Relevance  In certain circumstances, enucleating a melanoma-containing eye may unwittingly exacerbate metastatic disease. The results also suggest that exogenous angiostatin may have potential therapeutic implications in the management of patients with primary intraocular melanomas.

From the Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Measurement of Human Choroidal Melanoma Xenograft Volume in Rats Using High-Frequency Ultrasound
Braun and Vistisen
IOVS 2008;49:16-22.
ABSTRACT | FULL TEXT  

Modeling the Behavior of Uveal Melanoma in the Liver
Folberg et al.
IOVS 2007;48:2967-2974.
ABSTRACT | FULL TEXT  

Proton Beam Irradiation of Uveal Melanomas: The First 30 Years The Weisenfeld Lecture
Gragoudas
IOVS 2006;47:4666-4673.
FULL TEXT  

Treating some small melanocytic choroidal lesions without waiting for growth.
Shields
Arch Ophthalmol 2006;124:1344-1346.
FULL TEXT  

Orthotopic Human Choroidal Melanoma Xenografts in Nude Rats with Aggressive and Nonaggressive PAS Staining Patterns
Braun and Abbas
IOVS 2006;47:7-16.
ABSTRACT | FULL TEXT  

Whole-Body Bioluminescent Imaging of Human Uveal Melanoma in a New Mouse Model of Local Tumor Growth and Metastasis
Notting et al.
IOVS 2005;46:1581-1587.
ABSTRACT | FULL TEXT  

The Zimmerman-McLean-Foster hypothesis: 25 years later
Singh et al.
Br. J. Ophthalmol. 2004;88:962-967.
ABSTRACT | FULL TEXT  

Microcirculation and Tumor-Infiltrating Macrophages in Choroidal and Ciliary Body Melanoma and Corresponding Metastases
Toivonen et al.
IOVS 2004;45:1-6.
ABSTRACT | FULL TEXT  

Generation and role of angiostatin in human platelets
Jurasz et al.
Blood 2003;102:3217-3223.
ABSTRACT | FULL TEXT